These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 37754820)
1. Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy. Hailu FT; Karimpour-Fard A; Neltner B; Stauffer BL; Lipshultz S; Miyamoto SD; Sucharov CC J Cardiovasc Dev Dis; 2023 Sep; 10(9):. PubMed ID: 37754820 [TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of miRNA-mRNA interaction in pediatric dilated cardiomyopathy. Hailu FT; Karimpour-Fard A; Toni LS; Bristow MR; Miyamoto SD; Stauffer BL; Sucharov CC Pediatr Res; 2022 Jul; 92(1):98-108. PubMed ID: 34012027 [TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA-29-5p can add to the discrimination between dilated cardiomyopathy and ischaemic heart disease. Brundin M; Wågsäter D; Alehagen U; Carlhäll CJ ESC Heart Fail; 2021 Oct; 8(5):3865-3874. PubMed ID: 34173728 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy. Miyamoto SD; Karimpour-Fard A; Peterson V; Auerbach SR; Stenmark KR; Stauffer BL; Sucharov CC J Heart Lung Transplant; 2015 May; 34(5):724-33. PubMed ID: 25840506 [TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Fan KL; Zhang HF; Shen J; Zhang Q; Li XL Indian Heart J; 2013; 65(1):12-6. PubMed ID: 23438607 [TBL] [Abstract][Full Text] [Related]
6. Circulating miR-489 as a potential new biomarker for idiopathic dilated cardiomyopathy. Ishiguro T; Hayashi M; Fujiwara W; Okumura S; Yoshinaga M; Yamada R; Ueda S; Ito T; Niwa Y; Miyazaki A; Harada M; Naruse H; Ishii J; Ozaki Y; Izawa H Fujita Med J; 2021; 7(1):18-22. PubMed ID: 35111539 [TBL] [Abstract][Full Text] [Related]
7. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy. Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018 [TBL] [Abstract][Full Text] [Related]
8. Double overexpression of miR-19a and miR-20a in induced pluripotent stem cell-derived mesenchymal stem cells effectively preserves the left ventricular function in dilated cardiomyopathic rat. Sheu JJ; Chai HT; Sung PH; Chiang JY; Huang TH; Shao PL; Wu SC; Yip HK Stem Cell Res Ther; 2021 Jun; 12(1):371. PubMed ID: 34187571 [TBL] [Abstract][Full Text] [Related]
9. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy. Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584 [TBL] [Abstract][Full Text] [Related]
10. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs. Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy. Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501 [TBL] [Abstract][Full Text] [Related]
12. Circulating miRNA as novel markers for diastolic dysfunction. Nair N; Kumar S; Gongora E; Gupta S Mol Cell Biochem; 2013 Apr; 376(1-2):33-40. PubMed ID: 23247724 [TBL] [Abstract][Full Text] [Related]
13. Serum circulating proteins from pediatric patients with dilated cardiomyopathy cause pathologic remodeling and cardiomyocyte stiffness. Jeffrey DA; Pires Da Silva J; Garcia AM; Jiang X; Karimpour-Fard A; Toni LS; Lanzicher T; Peña B; Miyano CA; Nunley K; Korst A; Sbaizero O; Taylor MR; Miyamoto SD; Stauffer BL; Sucharov CC JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34383712 [TBL] [Abstract][Full Text] [Related]
14. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM. Li M; Chen X; Chen L; Chen K; Zhou J; Song J J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652 [TBL] [Abstract][Full Text] [Related]
15. Myocardial microRNAs associated with reverse remodeling in human heart failure. Sucharov CC; Kao DP; Port JD; Karimpour-Fard A; Quaife RA; Minobe W; Nunley K; Lowes BD; Gilbert EM; Bristow MR JCI Insight; 2017 Jan; 2(2):e89169. PubMed ID: 28138556 [TBL] [Abstract][Full Text] [Related]
17. A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy. Satoh M; Minami Y; Takahashi Y; Tabuchi T; Nakamura M J Card Fail; 2011 Nov; 17(11):923-9. PubMed ID: 22041329 [TBL] [Abstract][Full Text] [Related]
18. Plasma microRNA profiling of children with idiopathic dilated cardiomyopathy. Enes Coşkun M; Kervancıoğlu M; Öztuzcu S; Yılmaz Coşkun F; Ergün S; Başpınar O; Kılınç M; Temel L; Coşkun MY Biomarkers; 2016; 21(1):56-61. PubMed ID: 26631154 [TBL] [Abstract][Full Text] [Related]
19. Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls. Steudemann C; Bauersachs S; Weber K; Wess G BMC Vet Res; 2013 Jan; 9():12. PubMed ID: 23327631 [TBL] [Abstract][Full Text] [Related]